Skip to main content
Figure 5 | Journal of Translational Medicine

Figure 5

From: Aldosterone synthase inhibition: cardiorenal protection in animal disease models and translation of hormonal effects to human subjects

Figure 5

Pharmacokinetic profile of LCI699 following once-daily oral administration in humans. Plasma concentration–time profile for LCI699 (mg dose of phosphate salt) on Day 14 following once-daily oral administration in healthy human volunteers for 14 days. Values are mean ± SD. Number of evaluable subjects for LCI699 0.5, 1 and 3 mg were n = 12, 12 and 9 respectively.

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us